Profile for Sarepta Therapeutics Inc. (SRPT)

$ 112.39   -1.29 (-1.13%) Volume: 787.89k 4:00 PM EST 24-Jan-2020
After Hours:  $ 112.26   -0.13 (-0.12%) Volume: 18.78k 7:34 PM EST 24-Jan-2020
Business Description:
Sarepta Therapeutics Inc is a biotechnology company. It uses proprietary RNA-targeted technology platforms for developing pharmaceutical products to address serious diseases.
Address: 215 First Street, Suite 415, Cambridge, MA, USA, 02142
Telephone: +1 617 274-4000 Website: http://www.sarepta.com
Facsimile: N/A Email: [email protected]
Details
CEO: Douglas S. Ingram
Employees: 499 Market Cap: 8.38b
Issue Type: CS
Auditor: KPMG LLP
Last Audit: Unqualified Opinion
Indices: Biotechnology, DJ US Biotechnology, Morningstar Developed Markets Americas PR USD, Morningstar Developed Markets PR USD, Morningstar Global Markets PR USD, Morningstar US Defensive Super Sector PR USD, Morningstar US Growth PR USD, Morningstar US Healthcare Sector PR USD, Morningstar US Large-Mid Cap PR USD, Morningstar US Large-Mid Growth PR USD, Morningstar US Market Factor Tilt PR USD, Morningstar US Market PR USD, Morningstar US Mid Cap PR USD, Morningstar US Mid Growth PR USD, Morningstar US Small-Mid Cap PR USD, Morningstar US Small-Mid Growth PR USD
Industry Classifications
Sector: Healthcare CIK: 873303
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)